NutraLife BioSciences, Inc. (NLBS)

NutraLife BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	0	0.14	0	0.01	0.42
Cash & Cash Equivalents	0	0.14	0	0.01	0.42
Cash Growth	-	18197.71%	-95.00%	-96.47%	142.83%
Receivables	0	0.04	0.15	0.01	0.04
Inventory	0	0.31	0.57	0.49	0.29
Other Current Assets	0	0.03	0	0.09	0.12
Total Current Assets	0	0.52	0.72	0.6	0.87
Property, Plant & Equipment	0	2.71	2.98	3.17	0.93
Long-Term Investments	0	0.38	0.38	0	0
Intangible Assets	0	0.53	0.59	0.66	0
Other Long-Term Assets	0	0.71	0.04	0.04	0.04
Total Long-Term Assets	0	4.33	3.98	3.86	0.96
Total Assets	0	4.85	4.71	4.47	1.83
Accounts Payable	0	0.28	0.17	0.17	0.24
Deferred Revenue	0	0.07	0.02	0.01	0.08
Current Debt	0	2.78	2.54	1.33	0.2
Other Current Liabilities	0	2.07	1.05	0.68	0.47
Total Current Liabilities	0	5.2	3.78	2.19	1
Long-Term Debt	0	0.36	0.62	0.69	0.01
Total Long-Term Liabilities	0	0.36	0.62	0.69	0.01
Total Liabilities	0	5.56	4.41	2.88	1.02
Total Debt	0	3.14	3.16	2.02	0.22
Debt Growth	-	-0.46%	56.63%	824.35%	-
Common Stock	0	0.02	0.02	0.01	0.01
Retained Earnings	0	-47.56	-41.73	-38.84	-34.81
Comprehensive Income	0	0	0	-0	0
Shareholders' Equity	0	-0.71	0.3	1.59	0.82
Total Liabilities and Equity	0	4.85	4.71	4.47	1.83
Net Cash / Debt	0	-3.01	-3.16	-2	0.2
Net Cash / Debt Growth	-	-	-	-	16.75%
Net Cash Per Share	-	-0.02	-0.02	-0.02	0.00
Working Capital	0	-4.68	-3.06	-1.58	-0.13
Book Value Per Share	-	-0.00	0.00	0.01	0.01

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.